Revenue
2020
2021
Lysogene (LYS)
Price—Loading quote
Financial statements
| 2021 | 2020 | |
|---|---|---|
| Revenue | €7.2M | €16.6M |
| Research & development | €15.7M | €16.3M |
| Operating expenses | €20.5M | €21.7M |
| Operating income | −€13.3M | −€5.1M |
| Operating margin | −184.11% | −30.62% |
| EBITDA | −€13.1M | −€4.9M |
| EBITDA margin | −181.47% | −29.45% |
| Net income | −€13.6M | −€5.1M |
| Net profit margin | −188.52% | −30.70% |
| Basic EPSper basic share | -€0.81 | -€0.32 |
Owners
Reported shareholders and owner groups
20.60%of company shares
Sofinnova PartnersSource updated Jun 20, 2023
View holders
| Holder | Ownership |
|---|---|
| 20.60%Jun 20, 2023 | |
| 5.51%Jun 20, 2023 | |
| 4.10%Jun 20, 2023 | |
| 2.35%Jun 20, 2023 | |
| 2.27%Jun 20, 2023 |
These Euronext company-profile figures report shares in the company's capital. Named holders and owner groups are shown as published; free float, treasury shares, and unspecified holders are excluded from the colored segments.
This shareholder table is over two years old; current positions may differ.
Gray completes the 100% scale; it is not an estimate of other owners.
Source: Euronext / Cofisem ↗Checked Oct 21, 2026